141 related articles for article (PubMed ID: 25393877)
1. Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.
Seidensticker M; Seidensticker R; Damm R; Mohnike K; Pech M; Sangro B; Hass P; Wust P; Kropf S; Gademann G; Ricke J
PLoS One; 2014; 9(11):e112731. PubMed ID: 25393877
[TBL] [Abstract][Full Text] [Related]
2. Prevention of radiation-induced liver toxicity after interstitial HDR brachytherapy by pentoxifylline and ursodeoxycholic acid: patient compliance and outcome in a randomized trial.
Damm R; Wybranska J; Hass P; Walke M; Omari J; Pech M; Seidensticker R; Ricke J; Seidensticker M
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9043-9049. PubMed ID: 37166579
[TBL] [Abstract][Full Text] [Related]
3. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases.
Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
[TBL] [Abstract][Full Text] [Related]
4. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
5. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
6. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
[TBL] [Abstract][Full Text] [Related]
7. TNF-α Indicates Radiation-induced Liver Injury After Interstitial High Dose-rate Brachytherapy.
Damm R; Pech M; Haag F; Cavalli P; Gylstorff S; Omari J; Seidensticker R; Ricke J; Seidensticker M; Relja B
In Vivo; 2022; 36(5):2265-2274. PubMed ID: 36099091
[TBL] [Abstract][Full Text] [Related]
8. In vivo assessment of the tolerance dose of small liver volumes after single-fraction HDR irradiation.
Ricke J; Seidensticker M; Lüdemann L; Pech M; Wieners G; Hengst S; Mohnike K; Cho CH; Lopez Hänninen E; Al-Abadi H; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):776-84. PubMed ID: 15936559
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of liver metastases. Comparison of target volumes and dose-volume histograms employing CT- or MRI-based treatment planning.
Pech M; Mohnike K; Wieners G; Bialek E; Dudeck O; Seidensticker M; Peters N; Wust P; Gademann G; Ricke J
Strahlenther Onkol; 2008 May; 184(5):256-61. PubMed ID: 18427756
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced liver damage: correlation of histopathology with hepatobiliary magnetic resonance imaging, a feasibility study.
Seidensticker M; Burak M; Kalinski T; Garlipp B; Koelble K; Wust P; Antweiler K; Seidensticker R; Mohnike K; Pech M; Ricke J
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):213-21. PubMed ID: 24610229
[TBL] [Abstract][Full Text] [Related]
11. [CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases].
Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Lopez Hänninen E; Felix R
Strahlenther Onkol; 2004 May; 180(5):274-80. PubMed ID: 15127157
[TBL] [Abstract][Full Text] [Related]
12. Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
Rühl R; Lüdemann L; Czarnecka A; Streitparth F; Seidensticker M; Mohnike K; Pech M; Wust P; Ricke J
Radiat Oncol; 2010 May; 5():44. PubMed ID: 20507615
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO.
Pech M; Ricke J; Seidensticker M; Staskiewicz G; Wieners G; Mohnike K; Ruhl R; Steinberg J; Wust P; Seidensticker P
Int J Radiat Biol; 2008 Oct; 84(10):830-7. PubMed ID: 18979318
[TBL] [Abstract][Full Text] [Related]
14. Safety margin in irradiation of colorectal liver metastases: assessment of the control dose of micrometastases.
Seidensticker M; Wust P; Rühl R; Mohnike K; Pech M; Wieners G; Gademann G; Ricke J
Radiat Oncol; 2010 Mar; 5():24. PubMed ID: 20334657
[TBL] [Abstract][Full Text] [Related]
15. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
17. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
[TBL] [Abstract][Full Text] [Related]
18. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
19. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Hänninen EL; Felix R
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1496-505. PubMed ID: 15050329
[TBL] [Abstract][Full Text] [Related]
20. Value of combined PET/CT for radiation planning in CT-guided percutaneous interstitial high-dose-rate single-fraction brachytherapy for colorectal liver metastases.
Steffen IG; Wust P; Rühl R; Grieser C; Schnapauff D; Lüdemann L; Grabik W; Ricke J; Amthauer H; Hamm B; Hänninen EL; Denecke T
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1178-85. PubMed ID: 20056343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]